Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in Acute Ischemic Stroke
NCT00331890Phase 3Terminated
- Sponsor
- Ferrer
- Start
- Oct 2006
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of citicoline in ischemic stroke, sponsored by Ferrer. Started Oct 2006; status: terminated.
02
Drugs
citicoline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00331890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331890.